• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尿潴留对钬激光前列腺剜除术治疗良性前列腺增生症手术效果的影响。

Effect of urinary retention on the surgical outcome of holmium laser enucleation of the benign prostatic hyperplasia.

机构信息

Department of Urology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.

出版信息

Investig Clin Urol. 2023 Jan;64(1):31-40. doi: 10.4111/icu.20220232.

DOI:10.4111/icu.20220232
PMID:36629063
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9834565/
Abstract

PURPOSE

To evaluate the effect of urinary retention (UR) on holmium laser enucleation of the prostate (HoLEP) in patients with benign prostatic hyperplasia (BPH) and lower urinary tract symptoms.

MATERIALS AND METHODS

A retrospective analysis of a prospective cohort of patients who underwent HoLEP between January 2010 and December 2016 was performed. The perioperative factors, including the International Prostate Symptom Score, Overactive Bladder Symptom Score, prostate-specific antigen, urodynamic study results, uroflowmetry results, transrectal ultrasound prostate volume, operative time, morcellation time, enucleation weight, and complications, were evaluated. Postoperative evaluation was performed at 2, 3, and 6 months.

RESULTS

Overall, 903 patients were identified. The mean age and follow-up were 68.3 years and 6 months, respectively. Among the patients, 135 (15.0%) patients had a history of acute UR (AUR), and 36 patients (4.0%) had chronic UR (CUR). The mean detrusor pressures at maximum flow were 64.4, 74.3, and 77.7 cmHO (p<0.001). The mean maximum flow rates (Qmax) were 7.6, 6.6, and 4.8 mL/s (p<0.001). Additionally, the mean bladder outlet obstruction indices were 49.5, 61.1, and 69.4 (p<0.001). The postoperative Qmax improved in all three groups. The mean postvoid residual volumes (PVRs) were 55, 75, and 333 mL preoperatively; 20, 29, and 66 mL at 2 weeks; 16, 23, and 45 mL at 3 months; and 15, 22, and 52 mL at 6 months (p<0.001).

CONCLUSIONS

Voiding symptoms, PVR, and Qmax of BPH patients with preoperative AUR and CUR significantly improved after Ho-LEP, similar to those without preoperative UR.

摘要

目的

评估尿潴留(UR)对良性前列腺增生(BPH)和下尿路症状患者行钬激光前列腺剜除术(HoLEP)的影响。

材料与方法

对 2010 年 1 月至 2016 年 12 月期间行 HoLEP 的患者前瞻性队列进行回顾性分析。评估围手术期因素,包括国际前列腺症状评分、膀胱过度活动症症状评分、前列腺特异性抗原、尿动力学研究结果、尿流率结果、经直肠超声前列腺体积、手术时间、粉碎时间、剜除重量和并发症。术后 2、3 和 6 个月进行评估。

结果

共纳入 903 例患者,平均年龄为 68.3 岁,随访时间为 6 个月。其中 135 例(15.0%)患者有急性 UR(AUR)病史,36 例(4.0%)患者有慢性 UR(CUR)病史。最大尿流率时逼尿肌压力分别为 64.4、74.3 和 77.7cmH2O(p<0.001)。最大尿流率分别为 7.6、6.6 和 4.8mL/s(p<0.001)。此外,膀胱出口梗阻指数分别为 49.5、61.1 和 69.4(p<0.001)。三组患者术后最大尿流率均有改善。术前患者的剩余尿量(PVR)分别为 55、75 和 333mL;术后 2 周分别为 20、29 和 66mL;术后 3 个月分别为 16、23 和 45mL;术后 6 个月分别为 15、22 和 52mL(p<0.001)。

结论

与术前无 UR 患者相比,HoLEP 术后 AUR 和 CUR 的 BPH 患者的排尿症状、PVR 和最大尿流率均有显著改善。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e366/9834565/369f1cec36df/icu-64-31-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e366/9834565/b4ebdef6391c/icu-64-31-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e366/9834565/bf13213783ec/icu-64-31-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e366/9834565/79b1fe45ab86/icu-64-31-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e366/9834565/369f1cec36df/icu-64-31-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e366/9834565/b4ebdef6391c/icu-64-31-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e366/9834565/bf13213783ec/icu-64-31-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e366/9834565/79b1fe45ab86/icu-64-31-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e366/9834565/369f1cec36df/icu-64-31-g004.jpg

相似文献

1
Effect of urinary retention on the surgical outcome of holmium laser enucleation of the benign prostatic hyperplasia.尿潴留对钬激光前列腺剜除术治疗良性前列腺增生症手术效果的影响。
Investig Clin Urol. 2023 Jan;64(1):31-40. doi: 10.4111/icu.20220232.
2
Feasibility of holmium laser enucleation of the prostate (HoLEP) for recurrent/residual benign prostatic hyperplasia (BPH).钬激光前列腺剜除术(HoLEP)治疗复发性/残留良性前列腺增生(BPH)的可行性。
BJU Int. 2012 Dec;110(11 Pt C):E845-50. doi: 10.1111/j.1464-410X.2012.11290.x. Epub 2012 Jun 15.
3
Benign Prostatic Hyperplasia Endoscopic Surgical Procedures in Kidney Transplant Recipients: A Comparison Between Holmium Laser Enucleation of the Prostate, GreenLight Photoselective Vaporization of the Prostate, and Transurethral Resection of the Prostate.肾移植受者良性前列腺增生的内镜手术治疗:钬激光前列腺剜除术、绿激光前列腺汽化术和经尿道前列腺电切术的比较。
J Endourol. 2020 Feb;34(2):184-191. doi: 10.1089/end.2019.0430. Epub 2019 Nov 8.
4
Holmium:YAG transurethral incision versus laser photoselective vaporization for benign prostatic hyperplasia in a small prostate.钬激光经尿道前列腺切开术与激光光选择性汽化术治疗小前列腺良性前列腺增生的比较。
J Urol. 2014 Jan;191(1):148-54. doi: 10.1016/j.juro.2013.06.113. Epub 2013 Jul 8.
5
Holmium laser enucleation (HoLEP) and photoselective vaporisation of the prostate (PVP) for patients with benign prostatic hyperplasia (BPH) and chronic urinary retention.钬激光前列腺剜除术(HoLEP)和前列腺选择性光汽化术(PVP)治疗良性前列腺增生症(BPH)伴慢性尿潴留患者。
BJU Int. 2015 Feb;115(2):295-9. doi: 10.1111/bju.12674.
6
Bipolar plasma enucleation of the prostate vs open prostatectomy in large benign prostatic hyperplasia cases - a medium term, prospective, randomized comparison.经尿道双极等离子前列腺剜除术与开放性前列腺切除术治疗大体积良性前列腺增生症的中期前瞻性随机对照研究。
BJU Int. 2013 May;111(5):793-803. doi: 10.1111/j.1464-410X.2012.11730.x. Epub 2013 Mar 7.
7
A randomized trial comparing holmium laser enucleation of the prostate with transurethral resection of the prostate for the treatment of bladder outlet obstruction secondary to benign prostatic hyperplasia in large glands (40 to 200 grams).一项随机试验,比较钬激光前列腺剜除术与经尿道前列腺切除术治疗大腺体(40至200克)良性前列腺增生继发膀胱出口梗阻的疗效。
J Urol. 2003 Oct;170(4 Pt 1):1270-4. doi: 10.1097/01.ju.0000086948.55973.00.
8
Predictors of urgency improvement after Holmium laser enucleation of the prostate in men with benign prostatic hyperplasia.良性前列腺增生患者行钬激光前列腺剜除术后紧迫性改善的预测因素。
Investig Clin Urol. 2016 Nov;57(6):431-436. doi: 10.4111/icu.2016.57.6.431. Epub 2016 Oct 24.
9
[Transurethral resection of the prostate versus transurethral holmium laser enucleation of the prostate for benign prostatic hyperplasia with bladder detrusor overactivity].经尿道前列腺切除术与经尿道钬激光剜除术治疗合并膀胱逼尿肌过度活动症的良性前列腺增生症的对比研究
Zhonghua Nan Ke Xue. 2016 Aug;22(8):720-724.
10
[Safety and effect of transurethral holmium laser enucleation of the prostate versus bipolar transurethral plasmakinetic prostatectomy for benign prostatic hyperplasia: A meta-analysis].经尿道钬激光前列腺剜除术与双极经尿道等离子前列腺切除术治疗良性前列腺增生的安全性及疗效:一项荟萃分析
Zhonghua Nan Ke Xue. 2016 Oct;22(10):914-922.

引用本文的文献

1
Transurethral holmium laser enucleation of prostate shows remarkable efficacy in treating benign prostatic hyperplasia.经尿道钬激光前列腺剜除术在治疗良性前列腺增生方面显示出显著疗效。
Am J Transl Res. 2025 May 15;17(5):3665-3673. doi: 10.62347/RKJN6285. eCollection 2025.
2
Comparative study of HoLEP in elderly patients with indwelling catheters: a retrospective dual-center study.老年留置导尿管患者钬激光前列腺剜除术的比较研究:一项回顾性双中心研究。
World J Urol. 2025 Jan 16;43(1):75. doi: 10.1007/s00345-024-05437-9.

本文引用的文献

1
AUA White Paper on Nonneurogenic Chronic Urinary Retention: Consensus Definition, Treatment Algorithm, and Outcome End Points.AUA 白皮书:非神经原性慢性尿潴留:共识定义、治疗算法和结果终点。
J Urol. 2017 Jul;198(1):153-160. doi: 10.1016/j.juro.2017.01.075. Epub 2017 Feb 3.
2
Ischemia, Hypoxia and Oxidative Stress in Bladder Outlet Obstruction and Bladder Overdistention Injury.膀胱出口梗阻与膀胱过度扩张损伤中的缺血、缺氧及氧化应激
Low Urin Tract Symptoms. 2012 Mar;4 Suppl 1:27-31. doi: 10.1111/j.1757-5672.2011.00134.x.
3
Comparison of Holmium Laser Prostate Enucleation Outcomes in Patients with or without Preoperative Urinary Retention.
比较有或无术前尿潴留的前列腺钬激光剜除术患者的结果。
J Urol. 2016 Apr;195(4 Pt 1):1021-6. doi: 10.1016/j.juro.2015.10.116. Epub 2015 Oct 27.
4
Epidemiology and etiology of benign prostatic hyperplasia and bladder outlet obstruction.良性前列腺增生和膀胱出口梗阻的流行病学及病因学
Indian J Urol. 2014 Apr;30(2):170-6. doi: 10.4103/0970-1591.126900.
5
Holmium laser enucleation of the prostate: a review of the clinical trial evidence.钬激光前列腺剜除术:临床试验证据综述
Ther Adv Urol. 2014 Apr;6(2):62-73. doi: 10.1177/1756287213511509.
6
Holmium laser enucleation of the prostate versus transurethral resection of the prostate: a randomized clinical trial.钬激光前列腺剜除术与经尿道前列腺切除术:一项随机临床试验。
Int Urol Nephrol. 2014 Jul;46(7):1277-82. doi: 10.1007/s11255-014-0646-9. Epub 2014 Feb 4.
7
Urodynamics and safety of the β₃-adrenoceptor agonist mirabegron in males with lower urinary tract symptoms and bladder outlet obstruction.男性下尿路症状和膀胱出口梗阻患者中 β₃-肾上腺素能受体激动剂米拉贝隆的尿动力学和安全性。
J Urol. 2013 Oct;190(4):1320-7. doi: 10.1016/j.juro.2013.05.062. Epub 2013 May 30.
8
National trends in surgical therapy for benign prostatic hyperplasia in the United States (2000-2008).美国良性前列腺增生症手术治疗的国家趋势(2000-2008 年)。
Urology. 2012 May;79(5):1111-6. doi: 10.1016/j.urology.2011.11.084.
9
Laser prostatectomy of lower urinary tract symptoms due to benign prostate enlargement: a critical review of evidence.经尿道前列腺激光切除术治疗良性前列腺增生所致下尿路症状:证据的批判性回顾。
Curr Opin Urol. 2012 Jan;22(1):22-33. doi: 10.1097/MOU.0b013e32834dd0ed.
10
Update on AUA guideline on the management of benign prostatic hyperplasia.美国泌尿外科学会良性前列腺增生管理指南更新。
J Urol. 2011 May;185(5):1793-803. doi: 10.1016/j.juro.2011.01.074. Epub 2011 Mar 21.